Mednet are working with the Association of the British Pharmaceutical Industry, Pharmaceutical Mental Health Initiative, NHS England, College of Mental Health Pharmacists, Royal College of Psychiatrists, Royal College of GP’s, Royal College of Nurses, NHS Confederation and Royal Pharmaceutical Society on a national medicines optimisation project.
The project objectives are to
- Create an approved/ accredited resource that would address all aspects of medicines optimisation across the schizophrenia pathway
- Develop a digital toolkit for use across all stakeholders in primary care, linking with commissioner physical health targets
- Improve access & uptake of new medicines in this therapy area
Mednet are the project managers for this programme and the deliverables will be an accredited web based tool that enables primary care healthcare professionals to deliver best practices for medicines optimisation in the field of schizophrenia.